Andrew T. Lenis

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

1.8Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1283

Top 12%

1.8DataRank

Top 12%68 citations

Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Düzgöl, Samuel A. Funt +18 more

Papers

Driven by 18 papers — median percentile 88. Top paper: “Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience”.

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1283

Top 12%

1.8DataRank

Top 12%68 citations

Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Düzgöl, Samuel A. Funt +18 more

Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

Cell Reports(2022)10.1016/j.celrep.2022.111859

N/A

0.648DataRank · unranked

74 citations

Ziyu Chen, Hannah Wise, Andrew T. Lenis, Shweta S. Chavan, Mark T.A. Donoghue +20 more

Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3403

N/A

0.604DataRank · unranked

55 citations

Vignesh Ravichandran, Samantha Brown, Syed M. Alam, Andrew Katims, Hong Truong +25 more

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing

European Urology Oncology(2021)10.1016/j.euo.2021.09.005

N/A

0.553DataRank · unranked

39 citations

Rania Sheikh, Ritesh R. Kotecha, Yelena Kemel, Peter A. Reisz, Andrew T. Lenis +22 more

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

European Urology(2025)10.1016/j.eururo.2025.04.008

N/A

0.489DataRank · unranked

25 citations

Ziyu Chen, Karissa Whiting, Irina Ostrovnaya, Andrew T. Lenis, Timothy N. Clinton +26 more

Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer

European Urology(2023)10.1016/j.eururo.2022.08.028

N/A

0.449DataRank · unranked

19 citations

Kelsey Breen, Subhiksha Nandakumar, Daniel D. Sjoberg, Yelena Kemel, Nikita Mehta +34 more

Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma

European Urology(2024)10.1016/j.eururo.2024.10.024

N/A

0.385DataRank · unranked

12 citations

Syed M. Alam, Fengshen Kuo, Ziyu Chen, Wesley Yip, Andrew Katims +34 more

Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer

JCO Precision Oncology(2024)10.1200/po.23.00274

N/A

0.292DataRank · unranked

6 citations

Karissa Whiting, Vignesh Ravichandran, Jacob E. Tallman, Syed M. Alam, Carissa Chu +29 more

Defining hereditary upper tract urothelial carcinoma: Implications for genetic testing and clinical management.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.523

N/A

0.165DataRank · unranked

2 citations

Rania Sheikh, Yelena Kemel, Manuel De Jesus Escano, Aliya Khurram, Peter A. Reisz +15 more

Germline alterations in cancer susceptibility genes in women with high-risk bladder cancer: Implications for germline testing and clinical management.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.418

N/A

0.165DataRank · unranked

2 citations

Rania Sheikh, Aliya Khurram, Yelena Kemel, Andrew T. Lenis, Peter A. Reisz +10 more

Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.564

N/A

0.165DataRank · unranked

2 citations

Kwanghee Kim, Fengshen Kuo, Andrew T. Lenis, Jie‐Fu Chen, Wenhuo Hu +15 more

Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5022

N/A

0.104DataRank · unranked

1 citations

Kelsey Breen, Yelena Kemel, Andrew T. Lenis, Peter A. Reisz, Nicole Benfante +15 more

Genomic characterization of bladder cancer with variant histology.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.470

N/A

0DataRank · unranked

2 citations

Timothy N. Clinton, Wenhuo Hu, Nima Almassi, Peter A. Reisz, Hong Truong +12 more

Evaluation of germline genetic testing criteria in early-onset kidney cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.296

N/A

0DataRank · unranked

0 citations

Rania Sheikh, Ritesh R. Kotecha, Yelena Kemel, Aliya Khurram, Peter A. Reisz +15 more

Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.05.012

N/A

0DataRank · unranked

0 citations

John R. Christin, Clémentine Le Coz, Prakash Gorroochurn, Jamie S. Pak, Caroline Laplaca +8 more

Incidental Bladder Lesions on Prostate Multiparametric MRI: Prevalence and Factors Associated with Bladder Carcinoma

Academic Radiology(2025)10.1016/j.acra.2025.10.021

N/A

0DataRank · unranked

0 citations

Joshua Lee, Mutita Siriruchatanon, Zehui Gu, Chenchan Huang, Hawre Jalal +5 more

Detection of FGFR3 alt in plasma cfDNA in metastatic UC patients receiving Erda therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16519

N/A

0DataRank · unranked

0 citations

Min Yuen Teo, Samuel A. Funt, Chung‐Han Lee, David H. Aggen, Neha Ratna +11 more

Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non–muscle-invasive bladder cancer

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.04.006

N/A

0DataRank · unranked

3 citations

Emily Vertosick, Neeta D’Souza, Nicole Benfante, Andrew T. Lenis, Peter A. Reisz +14 more

Andrew T. Lenis

Indexed papers

Top data-sharing exemplar

Papers